FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

GDUFA Reauthorization Aids Public Health: FDA Execs

CDER executives say that GDUFA reauthorization helps public health by providing funds for the Centers work to bring generic drugs to market more quick...

Medical Devices

FDA Clears DePuy 510(k) for Maxframe Fixation Device

FDA clears a DePuy Synthes 510(k) for its recently launched Maxframe Multi-Axial Correction System, an external circular fixation device used to gradu...

FDA General

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that includes Diasol and Kelyniam Global.

Human Drugs

ICH Approves 2 Guidances

The International Council for Harmonization announces approval of two guidances and a question-and-answer document.

Human Drugs

Teva Files BLA for Migraine Prevention Therapy

Teva Pharmaceutical Industries files a BLA for fremanezumab, an anti-calcitonin gene-related peptide monoclonal antibody for preventing migraine heada...

FTC Expanding Enforcement Theories: Legal Analysis

Three attorneys look at the FTCs expanded efforts to regulate the line between permitted and potentially anticompetitive conduct by drug companies.

Human Drugs

Court Dismisses Most Allegations in Generic Cordarone Suit

A Kentucky federal court dismisses a suit against Zydus raising seven allegations about the companys generic form of Cordarone.

Federal Register

Class 2 for Enzyme Packed Cartridges

Federal Register notice: FDA classifies enzyme packed cartridges into Class 2 (special controls).

Federal Register

FDA Corrects Docket Number on 27 Withdrawn ANDAs

Federal Register notice: FDA corrects a 9/21 Federal Register notice that announced the withdrawal of approval of 27 abbreviated new drug applications...

Federal Register

Draft Guide on Complete Response Meetings

Federal Register notice: FDA makes available a draft guidance entitled Post-Complete Response Letter Meetings Between FDA and ANDA Applicants Under GD...